May 23, 2019
Two Japanese oncology societies have compiled pharmacotherapy guidelines for elderly cancer patients, the first of its kind in Japan, recommending use of bevacizumab in unresectable advanced/relapsed colorectal cancer patients and immune checkpoint inhibitors for progressive non-small cell lung cancer (NSCLC)...read more